Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

J. Michael Gaziano, M.D.

Co-Author

This page shows the publications co-authored by J. Gaziano and Meir Stampfer.
Connection Strength

3.084
  1. Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. Lancet Oncol. 2008 Nov; 9(11):1039-47.
    View in: PubMed
    Score: 0.102
  2. Aspirin and decreased adult-onset asthma: randomized comparisons from the physicians' health study. Am J Respir Crit Care Med. 2007 Jan 15; 175(2):120-5.
    View in: PubMed
    Score: 0.089
  3. Dyslipidemia and the risk of incident hypertension in men. Hypertension. 2006 Jan; 47(1):45-50.
    View in: PubMed
    Score: 0.084
  4. Prospective study of plasma carotenoids and tocopherols in relation to risk of ischemic stroke. Stroke. 2004 Jul; 35(7):1584-8.
    View in: PubMed
    Score: 0.075
  5. Predictors of 14-year changes in the total cholesterol to high-density lipoprotein cholesterol ratio in men. Am Heart J. 2004 Jun; 147(6):1033-8.
    View in: PubMed
    Score: 0.075
  6. A prospective study of plasma C-peptide and colorectal cancer risk in men. J Natl Cancer Inst. 2004 Apr 07; 96(7):546-53.
    View in: PubMed
    Score: 0.075
  7. Cholesterol and the risk of ischemic stroke. Stroke. 2003 Dec; 34(12):2930-4.
    View in: PubMed
    Score: 0.073
  8. Analgesic use and change in kidney function in apparently healthy men. Am J Kidney Dis. 2003 Aug; 42(2):234-44.
    View in: PubMed
    Score: 0.071
  9. Milk intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in men. J Natl Cancer Inst. 2001 Sep 05; 93(17):1330-6.
    View in: PubMed
    Score: 0.062
  10. Analgesic use and renal function in men. JAMA. 2001 Jul 18; 286(3):315-21.
    View in: PubMed
    Score: 0.062
  11. Seven-year changes in alcohol consumption and subsequent risk of cardiovascular disease in men. Arch Intern Med. 2000 Sep 25; 160(17):2605-12.
    View in: PubMed
    Score: 0.058
  12. Light-to-moderate alcohol consumption and mortality in the Physicians' Health Study enrollment cohort. J Am Coll Cardiol. 2000 Jan; 35(1):96-105.
    View in: PubMed
    Score: 0.056
  13. Circulating high sensitivity C reactive protein concentrations and risk of lung cancer: nested case-control study within Lung Cancer Cohort Consortium. BMJ. 2019 01 03; 364:k4981.
    View in: PubMed
    Score: 0.052
  14. Circulating cotinine concentrations and lung cancer risk in the Lung Cancer Cohort Consortium (LC3). Int J Epidemiol. 2018 12 01; 47(6):1760-1771.
    View in: PubMed
    Score: 0.052
  15. Body Mass Index, Diabetes and Intrahepatic Cholangiocarcinoma Risk: The Liver Cancer Pooling Project and Meta-analysis. Am J Gastroenterol. 2018 10; 113(10):1494-1505.
    View in: PubMed
    Score: 0.051
  16. Impaired functional vitamin B6 status is associated with increased risk of lung cancer. Int J Cancer. 2018 06 15; 142(12):2425-2434.
    View in: PubMed
    Score: 0.048
  17. Circulating Folate, Vitamin B6, and Methionine in Relation to Lung Cancer Risk in the Lung Cancer Cohort Consortium (LC3). J Natl Cancer Inst. 2018 01 01; 110(1).
    View in: PubMed
    Score: 0.048
  18. Circulating concentrations of biomarkers and metabolites related to vitamin status, one-carbon and the kynurenine pathways in US, Nordic, Asian, and Australian populations. Am J Clin Nutr. 2017 06; 105(6):1314-1326.
    View in: PubMed
    Score: 0.046
  19. Cigarette Smoking and Pancreatic Cancer Survival. J Clin Oncol. 2017 Jun 01; 35(16):1822-1828.
    View in: PubMed
    Score: 0.046
  20. Interactions Between Genome-Wide Significant Genetic Variants and Circulating Concentrations of 25-Hydroxyvitamin D in Relation to Prostate Cancer Risk in the National Cancer Institute BPC3. Am J Epidemiol. 2017 03 15; 185(6):452-464.
    View in: PubMed
    Score: 0.046
  21. Regular Aspirin Use and the Risk of Lethal Prostate Cancer in the Physicians' Health Study. Eur Urol. 2017 11; 72(5):821-827.
    View in: PubMed
    Score: 0.045
  22. Prospective study of moderate alcohol consumption and mortality in US male physicians. Arch Intern Med. 1997 Jan 13; 157(1):79-85.
    View in: PubMed
    Score: 0.045
  23. Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic Polymorphisms. Cancer Res. 2016 12 15; 76(24):7160-7167.
    View in: PubMed
    Score: 0.045
  24. Leucocyte telomere length, genetic variants at the TERT gene region and risk of pancreatic cancer. Gut. 2017 06; 66(6):1116-1122.
    View in: PubMed
    Score: 0.045
  25. Prediagnostic Plasma 25-Hydroxyvitamin D and Pancreatic Cancer Survival. J Clin Oncol. 2016 08 20; 34(24):2899-905.
    View in: PubMed
    Score: 0.043
  26. Circulating Metabolites and Survival Among Patients With Pancreatic Cancer. J Natl Cancer Inst. 2016 Jun; 108(6):djv409.
    View in: PubMed
    Score: 0.042
  27. Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types. J Natl Cancer Inst. 2015 Dec; 107(12):djv279.
    View in: PubMed
    Score: 0.041
  28. Discrimination in absorption or transport of beta-carotene isomers after oral supplementation with either all-trans- or 9-cis-beta-carotene. Am J Clin Nutr. 1995 Jun; 61(6):1248-52.
    View in: PubMed
    Score: 0.040
  29. Further Confirmation of Germline Glioma Risk Variant rs78378222 in TP53 and Its Implication in Tumor Tissues via Integrative Analysis of TCGA Data. Hum Mutat. 2015 Jul; 36(7):684-8.
    View in: PubMed
    Score: 0.040
  30. A genome-wide pleiotropy scan for prostate cancer risk. Eur Urol. 2015 Apr; 67(4):649-57.
    View in: PubMed
    Score: 0.039
  31. Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Nat Med. 2014 10; 20(10):1193-1198.
    View in: PubMed
    Score: 0.039
  32. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. Hum Mol Genet. 2014 Dec 15; 23(24):6616-33.
    View in: PubMed
    Score: 0.038
  33. Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survival. J Natl Cancer Inst. 2014 Jun; 106(6):dju085.
    View in: PubMed
    Score: 0.038
  34. Body size and multiple myeloma mortality: a pooled analysis of 20 prospective studies. Br J Haematol. 2014 Sep; 166(5):667-76.
    View in: PubMed
    Score: 0.038
  35. Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Eur Urol. 2014 Jun; 65(6):1069-75.
    View in: PubMed
    Score: 0.037
  36. Hyperglycemia, insulin resistance, impaired pancreatic ß-cell function, and risk of pancreatic cancer. J Natl Cancer Inst. 2013 Jul 17; 105(14):1027-35.
    View in: PubMed
    Score: 0.035
  37. Mannose-binding lectin 2 gene and risk of adult glioma. PLoS One. 2013; 8(4):e61117.
    View in: PubMed
    Score: 0.035
  38. Single-nucleotide polymorphisms of allergy-related genes and risk of adult glioma. J Neurooncol. 2013 Jun; 113(2):229-38.
    View in: PubMed
    Score: 0.035
  39. Inflammatory plasma markers and pancreatic cancer risk: a prospective study of five U.S. cohorts. Cancer Epidemiol Biomarkers Prev. 2013 May; 22(5):855-61.
    View in: PubMed
    Score: 0.035
  40. Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium. Cancer Epidemiol Biomarkers Prev. 2013 Apr; 22(4):688-96.
    View in: PubMed
    Score: 0.034
  41. A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts. J Natl Cancer Inst. 2013 Jan 16; 105(2):95-103.
    View in: PubMed
    Score: 0.034
  42. Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and Prostate Cancer Cohort Consortium. Am J Epidemiol. 2012 Dec 15; 176(12):1121-9.
    View in: PubMed
    Score: 0.034
  43. Genome-wide association study of glioma and meta-analysis. Hum Genet. 2012 Dec; 131(12):1877-88.
    View in: PubMed
    Score: 0.033
  44. Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Am J Epidemiol. 2012 May 01; 175(9):926-35.
    View in: PubMed
    Score: 0.032
  45. Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). Cancer Epidemiol Biomarkers Prev. 2012 Mar; 21(3):437-44.
    View in: PubMed
    Score: 0.032
  46. Beta-carotene antioxidant use during radiation therapy and prostate cancer outcome in the Physicians' Health Study. Int J Radiat Oncol Biol Phys. 2012 May 01; 83(1):28-32.
    View in: PubMed
    Score: 0.032
  47. Prediagnostic plasma IgE levels and risk of adult glioma in four prospective cohort studies. J Natl Cancer Inst. 2011 Nov 02; 103(21):1588-95.
    View in: PubMed
    Score: 0.031
  48. Genome-wide association study identifies new prostate cancer susceptibility loci. Hum Mol Genet. 2011 Oct 01; 20(19):3867-75.
    View in: PubMed
    Score: 0.031
  49. Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer. PLoS One. 2011 Apr 06; 6(4):e18625.
    View in: PubMed
    Score: 0.030
  50. Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3. PLoS One. 2011 Feb 24; 6(2):e17142.
    View in: PubMed
    Score: 0.030
  51. Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer. Cancer Epidemiol Biomarkers Prev. 2010 Nov; 19(11):2877-87.
    View in: PubMed
    Score: 0.029
  52. A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. J Clin Endocrinol Metab. 2010 Sep; 95(9):E121-7.
    View in: PubMed
    Score: 0.029
  53. A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians. Hum Mol Genet. 2010 Aug 01; 19(15):3089-101.
    View in: PubMed
    Score: 0.029
  54. PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3). Carcinogenesis. 2010 Mar; 31(3):455-61.
    View in: PubMed
    Score: 0.028
  55. CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev. 2009 Oct; 18(10):2734-44.
    View in: PubMed
    Score: 0.027
  56. Polymorphism in endostatin, an angiogenesis inhibitor, and prostate cancer risk and survival: A prospective study. Int J Cancer. 2009 Sep 01; 125(5):1143-6.
    View in: PubMed
    Score: 0.027
  57. Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3). Hum Mol Genet. 2009 Oct 01; 18(19):3749-57.
    View in: PubMed
    Score: 0.027
  58. Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility. Proc Natl Acad Sci U S A. 2009 May 12; 106(19):7933-8.
    View in: PubMed
    Score: 0.026
  59. Effects of G/A polymorphism, rs266882, in the androgen response element 1 of the PSA gene on prostate cancer risk, survival and circulating PSA levels. Br J Cancer. 2008 Nov 18; 99(10):1743-7.
    View in: PubMed
    Score: 0.025
  60. Prostate cancer risk and ESR1 TA, ESR2 CA repeat polymorphisms. Cancer Epidemiol Biomarkers Prev. 2007 Nov; 16(11):2233-6.
    View in: PubMed
    Score: 0.024
  61. CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). Cancer Epidemiol Biomarkers Prev. 2007 Nov; 16(11):2237-46.
    View in: PubMed
    Score: 0.024
  62. Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev. 2007 Oct; 16(10):1973-81.
    View in: PubMed
    Score: 0.024
  63. The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol. 2007; 22(12):839-69.
    View in: PubMed
    Score: 0.024
  64. Hypoxia-inducible factor-1alpha (HIF-1alpha) gene polymorphisms, circulating insulin-like growth factor binding protein (IGFBP)-3 levels and prostate cancer. Prostate. 2007 Sep 01; 67(12):1354-61.
    View in: PubMed
    Score: 0.024
  65. A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Res. 2007 Apr 01; 67(7):2951-6.
    View in: PubMed
    Score: 0.023
  66. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer. PLoS Med. 2007 Mar; 4(3):e103.
    View in: PubMed
    Score: 0.023
  67. Plasma C-peptide and cognitive performance in older men without diabetes. Am J Geriatr Psychiatry. 2006 Dec; 14(12):1041-50.
    View in: PubMed
    Score: 0.022
  68. Healthy lifestyle and the risk of stroke in women. Arch Intern Med. 2006 Jul 10; 166(13):1403-9.
    View in: PubMed
    Score: 0.022
  69. Homocysteine and risk of developing hypertension in men. J Hum Hypertens. 2006 Aug; 20(8):631-4.
    View in: PubMed
    Score: 0.022
  70. A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer. 2005 12; 5(12):977-85.
    View in: PubMed
    Score: 0.021
  71. Genetic variation in the HSD17B1 gene and risk of prostate cancer. PLoS Genet. 2005 Nov; 1(5):e68.
    View in: PubMed
    Score: 0.021
  72. Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer. Cancer Res. 2005 Mar 15; 65(6):2498-504.
    View in: PubMed
    Score: 0.020
  73. A prospective study of plasma selenium levels and prostate cancer risk. J Natl Cancer Inst. 2004 May 05; 96(9):696-703.
    View in: PubMed
    Score: 0.019
  74. Plasma carotenoids and tocopherols and risk of myocardial infarction in a low-risk population of US male physicians. Circulation. 2003 Aug 19; 108(7):802-7.
    View in: PubMed
    Score: 0.018
  75. Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. J Natl Cancer Inst. 2002 Jul 17; 94(14):1099-106.
    View in: PubMed
    Score: 0.017
  76. Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study. Am J Clin Nutr. 2001 Oct; 74(4):549-54.
    View in: PubMed
    Score: 0.016
  77. Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction. N Engl J Med. 2001 Feb 22; 344(8):549-55.
    View in: PubMed
    Score: 0.015
  78. Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in Men. Hypertension. 2000 Nov; 36(5):801-7.
    View in: PubMed
    Score: 0.015
  79. Two-year changes in blood pressure and subsequent risk of cardiovascular disease in men. Circulation. 2000 Jul 18; 102(3):307-12.
    View in: PubMed
    Score: 0.014
  80. Moderate alcohol consumption and risk for angina pectoris or myocardial infarction in U.S. male physicians. Ann Intern Med. 1997 Mar 01; 126(5):372-5.
    View in: PubMed
    Score: 0.011
  81. Prospective study of moderate alcohol consumption and risk of peripheral arterial disease in US male physicians. Circulation. 1997 Feb 04; 95(3):577-80.
    View in: PubMed
    Score: 0.011
  82. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 1996 May 02; 334(18):1145-9.
    View in: PubMed
    Score: 0.011
  83. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. Am J Epidemiol. 1996 May 01; 143(9):845-59.
    View in: PubMed
    Score: 0.011
  84. Aspirin in the primary prevention of angina pectoris in a randomized trial of United States physicians. Am J Med. 1990 Dec; 89(6):772-6.
    View in: PubMed
    Score: 0.007
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.